JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160
JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160
摩根大通将阿里拉姆制药的目标股价由160美元上调至248美元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册